Researchers at Weill Cornell Medicine recently discovered that low levels of folate, a B vitamin essential for cell growth, can trigger specific genetic changes found in several human cancers, including lung tumors.
Dopamine neurons in a part of the brain called the midbrain may, with aging, be increasingly susceptible to a vicious spiral of decline driven by fuel shortages, according to a study led by Weill Cornell Medicine investigators.
More than 75 employees were honored in this year’s ceremony, representing Cornell’s Ithaca campus as well as Weill Cornell Medicine in New York City and Weill Cornell Medicine-Qatar.
Vice President and General Counsel Donica Thomas Varner has announced plans to step down from her position effective Feb. 6, 2026. The university will conduct a national search for her replacement.
In 2025, four companies with Cornell-originated technologies — SafetyStratus, Bactana Corporation, Guard Medical and Halo Labs — were acquired by global corporate partners, allowing Cornell technologies to reach broader markets.
Dr. Despina Siolas, assistant professor of medicine at Weill Cornell Medicine and an oncologist at NewYork-Presbyterian/Weill Cornell Medical Center, is working on personalizing treatment for pancreatic cancer, which is often diagnosed too late.
Chemotherapy activates a stress sensor in immune cells, which may help explain why many cancer patients experience debilitating pain as a side effect, according to Weill Cornell Medicine and Wake Forest University researchers.